World Health Organization Geneva. WHO policy perspectives on medicines. pharmacovigilance: ensuring the safe use of medicines[EB/OL]. 2004-10-02. http://apps.who.int/medicinedocs/en/d/Js6164e/.
[14]
World Health Organization. The importance of pharmacovigilance:safety monitoring of medicinal products[EB/OL]. 2002-02-01.http://apps.who.int/medicinedocs/en/d/Js4893e/.
[15]
World Health Organization Geneva. Safety of medicines:a guide to detecting and reporting adverse drug reactions[EB/OL]. 2002-02-01.http://apps.who.int/medicinedocs/en/d/Jh2992e/.
[16]
World Health Organization Geneva. Guidelines on safety monitoring of herbal medicines in pharmacovigilance systems[EB/OL]. 2004-10-02.http://apps.who.int/medicinedocs/en/m/abstract/Js7148e/.
[17]
Food and Drug Administration. Federal food, drug, and cosmetic act[EB/OL]. 2006-05-01. http://en.wikipedia.org/wiki/Federal_Food,_Drug,_and_Cosmetic_Act.
[18]
Food and Drug Administration. Food and drug administration amendments act of 2007[EB/OL].2007-10-01. http://en. wikipedia. org/wiki/Food_and_Drug_Administration_Amendments_Act_of_2007.
[19]
Food and Drug Administration. Good pharmacovigilance practices and pharmacoepidemiologic assessment[EB/OL].2005-01-01.http://www.fda.gov/cder/guidance/index.htm.
[20]
Food and Drug Administration. Guideline for postmarketing reporting of adverse drug experiences[EB/OL].2001-01-01. http://www.fda.gov/cder/guidance/index.htm.
[21]
Food and Drug Administration. Society of health system pharmacists ASHP guidelines on adverse drug reaction monitoring and reporting[EB/OL].2005-01-01.http://www.ashp.org/s_ashp/docs/files/MedMis_Gdl_ADR.pdf.
[22]
European Commission.Directive 2001／83／EC of the European parliament and of the council of 6 November 2001 on the community code relating to medicinal products for human use[EB/OL]. 2001-01-01. http://apps.who.int/medicinedocs/en/m/abstract/Js17096e/.
Wilcox C M, Allison J, Benzuly K, Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin. [J].Clin Gastronenterol Hepatol,2006,4(9):1082.
